Latest News of CRMD
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic
CorMedix Inc. (CRMD) shareholders are optimistic as analysts upgraded revenue and earnings forecasts for next year. Predicted revenues for 2025 are $111m, and EPS is estimated at $0.45. Despite the po...
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate
CorMedix Inc. (NASDAQ:CRMD) shares dropped 23% in the past week after soaring 188% in the last year. Despite no profits, revenue grew by 41,184%, driving the stock price rise....
CorMedix Inc. (CRMD): A Bull Case Theory
CorMedix Inc.'s bullish thesis on ValueInvesting subreddit highlights DefenCath, an innovative catheter lock solution reducing infections in hemodialysis patients....